Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations
Adult
0301 basic medicine
COMPLEX DISEASES
SUSCEPTIBILITY LOCI
Adolescent
SYNDROME PCOS
Quantitative Trait Loci
CHROMOSOME 2P16.3
VARIANTS
Polymorphism, Single Nucleotide
Article
White People
Young Adult
03 medical and health sciences
QUALITY-CONTROL
616
MD Multidisciplinary
Humans
ANDROGEN EXCESS
Reproductive Medicine Network
Science & Technology
EMERGE NETWORK
IDENTIFICATION
WOMEN
Middle Aged
3. Good health
Multidisciplinary Sciences
Gene Expression Regulation
Case-Control Studies
Science & Technology - Other Topics
Female
Genome-Wide Association Study
Polycystic Ovary Syndrome
DOI:
10.1038/ncomms8502
Publication Date:
2015-08-18T14:57:44Z
AUTHORS (56)
ABSTRACT
AbstractPolycystic ovary syndrome (PCOS) is a common, highly heritable complex disorder of unknown aetiology characterized by hyperandrogenism, chronic anovulation and defects in glucose homeostasis. Increased luteinizing hormone relative to follicle-stimulating hormone secretion, insulin resistance and developmental exposure to androgens are hypothesized to play a causal role in PCOS. Here we map common genetic susceptibility loci in European ancestry women for the National Institutes of Health PCOS phenotype, which confers the highest risk for metabolic morbidities, as well as reproductive hormone levels. Three loci reach genome-wide significance in the case–control meta-analysis, two novel loci mapping to chr 8p23.1 and chr 11p14.1, and a chr 9q22.32 locus previously found in Chinese PCOS. The same chr 11p14.1 SNP, rs11031006, in the region of the follicle-stimulating hormone B polypeptide (FSHB) gene strongly associates with PCOS diagnosis and luteinizing hormone levels. These findings implicate neuroendocrine changes in disease pathogenesis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (69)
CITATIONS (313)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....